| Primary |
| Type 2 Diabetes Mellitus |
21.9% |
| Type 1 Diabetes Mellitus |
17.4% |
| Diabetes Mellitus |
13.6% |
| Insulin-requiring Type Ii Diabetes Mellitus |
9.1% |
| Drug Use For Unknown Indication |
8.0% |
| Hypertension |
5.4% |
| Diabetes Mellitus Insulin-dependent |
4.0% |
| Product Used For Unknown Indication |
4.0% |
| Insulin-requiring Type 2 Diabetes Mellitus |
2.7% |
| Chest Pain |
2.1% |
| Diabetes Mellitus Non-insulin-dependent |
2.1% |
| Depression |
1.4% |
| Diabetic Neuropathy |
1.4% |
| Hyperglycaemia |
1.4% |
| Cataract |
1.2% |
| Benign Prostatic Hyperplasia |
1.0% |
| Constipation |
0.9% |
| Cardiomegaly |
0.8% |
| Cerebral Infarction |
0.8% |
| Hyperlipidaemia |
0.7% |
|
| Hypoglycaemia |
21.8% |
| Suicide Attempt |
8.2% |
| Vomiting |
7.1% |
| Intentional Overdose |
6.5% |
| Rash |
5.9% |
| Blood Glucose Increased |
5.3% |
| Hypoglycaemic Unconsciousness |
4.1% |
| Pneumonia |
4.1% |
| Product Quality Issue |
4.1% |
| Blood Glucose Fluctuation |
3.5% |
| Diabetes Mellitus Inadequate Control |
3.5% |
| Loss Of Consciousness |
3.5% |
| Medication Error |
3.5% |
| Drug Hypersensitivity |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Hypersensitivity |
2.9% |
| Urticaria |
2.9% |
| Anti-insulin Antibody Positive |
2.4% |
| Diabetic Ketoacidosis |
2.4% |
| Pyrexia |
2.4% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
29.0% |
| Diabetes Mellitus |
15.0% |
| Type 1 Diabetes Mellitus |
12.7% |
| Insulin-requiring Type Ii Diabetes Mellitus |
7.8% |
| Hypertension |
6.8% |
| Drug Use For Unknown Indication |
5.7% |
| Insulin-requiring Type 2 Diabetes Mellitus |
5.0% |
| Product Used For Unknown Indication |
4.2% |
| Chest Pain |
2.7% |
| Suicide Attempt |
1.7% |
| Diabetes Mellitus Insulin-dependent |
1.3% |
| Hyperlipidaemia |
1.2% |
| Cerebral Infarction |
1.2% |
| Insomnia |
0.9% |
| Constipation |
0.8% |
| Device Therapy |
0.8% |
| Malnutrition |
0.8% |
| Prophylaxis |
0.8% |
| Angina Pectoris |
0.7% |
| Cardiac Failure Chronic |
0.7% |
|
| Hypoglycaemia |
23.2% |
| Vomiting |
7.4% |
| Blood Glucose Increased |
6.9% |
| Suicide Attempt |
6.4% |
| Hepatic Function Abnormal |
5.9% |
| Urinary Tract Infection |
5.4% |
| Diabetes Mellitus Inadequate Control |
4.4% |
| Injection Site Pain |
4.4% |
| Diabetic Ketoacidosis |
3.9% |
| Blood Glucose Fluctuation |
3.4% |
| Urine Ketone Body Present |
3.4% |
| Drug Hypersensitivity |
3.0% |
| Influenza |
3.0% |
| Injection Site Reaction |
3.0% |
| Intentional Overdose |
3.0% |
| Loss Of Consciousness |
3.0% |
| Product Colour Issue |
3.0% |
| Liver Disorder |
2.5% |
| Pulmonary Oedema |
2.5% |
| Renal Impairment |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.0% |
| Diabetes Mellitus |
15.9% |
| Drug Use For Unknown Indication |
14.6% |
| Hypertension |
9.3% |
| Prophylaxis |
7.3% |
| Type 2 Diabetes Mellitus |
5.0% |
| Type 1 Diabetes Mellitus |
2.9% |
| Acute Lymphocytic Leukaemia |
2.7% |
| Pain |
2.0% |
| Depression |
1.9% |
| Fluid Replacement |
1.7% |
| Multiple Myeloma |
1.7% |
| Insomnia |
1.6% |
| Constipation |
1.5% |
| Hyperlipidaemia |
1.5% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Infection Prophylaxis |
1.4% |
| Myelodysplastic Syndrome |
1.2% |
| Nausea |
1.2% |
| Nuclear Magnetic Resonance Imaging |
1.2% |
|
| Weight Decreased |
9.1% |
| Vomiting |
8.4% |
| Sepsis |
6.7% |
| Renal Failure Acute |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Thrombocytopenia |
5.7% |
| Death |
4.9% |
| Interstitial Lung Disease |
4.7% |
| Oedema Peripheral |
4.7% |
| Hepatic Function Abnormal |
4.4% |
| Hypoglycaemia |
4.4% |
| Myocardial Infarction |
4.4% |
| Urinary Tract Infection |
4.4% |
| Weight Increased |
4.2% |
| Blood Glucose Increased |
3.9% |
| Loss Of Consciousness |
3.9% |
| Pneumonia |
3.9% |
| Pyrexia |
3.7% |
| Renal Failure |
3.7% |
| Renal Impairment |
3.0% |
|
| Interacting |
| Diabetes Mellitus |
33.3% |
| Cardiac Failure Chronic |
16.7% |
| Cerebral Infarction |
16.7% |
| Hypertension |
16.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
16.7% |
|
|
